Pay in 4 interest-free payments of $7.13 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
"This is the first step in being able to use someone's genetic makeup to help us improve that decision-making process." In their analysis, the researchers compared 19 people with the PAM gene variant p.S539W to 19 matched controls, studying how their bodies tolerated consuming a sugary drink
Clinical Trial Evidence The head-to-head comparison comes from the SURPASS clinical trial program for diabetes and SURMOUNT program for weight loss
Meet Our Experts See Our Editorial Policy Meet Our Health Expert Network Sandy Bassin, MD Medical Reviewer Member of American College of Lifestyle Medicine Sandy Bassin, MD, is an endocrinology fellow at Mount Sinai in New York City
both were fully described so that the former could support the interpretation of the latter
Thats welcome news
Primary endpoint Percentage weight loss at M6 was statistically significantly higher in the GLP-1-RA group than in the UCWM group (12.0% [3.3] vs
